COVID-19 Pharmaceutical Consumables Expansion and Acceleration: Biocontainer, Bottle, Freeze/Thaw and Filling Assemblies; and Fluid Transfer and Filtration Sets

This combined synopsis and solicitation from the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services seeks proposals to expand and accelerate domestic manufacturing capacity for biocontainer, bottle, freeze/thaw and filling assemblies as well as fluid transfer and filtration sets in support of COVID-19 vaccine developers through June 2023. Offerors must propose plans and milestones to build out additional cleanroom manufacturing space by specified dates and will receive fixed payments totaling up to $15 million if qualification criteria are met. Proposals are due by February 23rd and the agency intends to award a firm fixed price contract with payable milestones tied to completion criteria, evaluating technical approach, past performance, and price using detailed cost templates provided.

There is no set-aside designated for this opportunity. NAICS codes 325414 and 335912 for biological product and fluid power valve and hose fitting manufacturing are applicable. The place of performance is within the United States and award value may reach $15 million to support demand through 2023. Successful offerors must qualify additional cleanroom space on milestones between award and June 2023 to receive payments, expanding domestic capacity for consumables like biocontainers and fluid transfer equipment critical to COVID-19 vaccine production.